Effects of renal insufficiency on pharmacokinetics of methotrexate (MTX) in rheumatoid arthritis (RA) patients.

被引：0
|
作者：
Combe, B
Kinowski, JM
Bologna, C
Sany, J
Bressolle, F
机构：
[1] HOP LAPEYRONIE,SERV IMMUNORHUMATOL,MONTPELLIER,FRANCE
[2] FAC PHARM MONTPELLIER,MONTPELLIER,FRANCE
来源：
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [31] Development of a New Methotrexate (MTX)-Specific Adherence Tool for Use in the Management of Patients with Rheumatoid Arthritis (RA)
    Curtis, Jeffrey R.
    Aassi, Maher
    Barbosa, Carla Dias
    Bernasconi, Corrado
    Brethous, Michel
    Arnould, Benoit
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 493 - 494
  • [32] SELECTIVE VS UNSELECTIVE LIVER BIOPSIES IN METHOTREXATE (MTX)-TREATED RHEUMATOID-ARTHRITIS (RA) PATIENTS
    ALARCON, GS
    LIGHTFOOT, RW
    KREMER, JM
    WEINBLATT, ME
    WILLKENS, RF
    WILLIAMS, HJ
    FURST, DE
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S64 - S64
  • [33] Genotoxicity assessment using micronuclei assay (MN) in rheumatoid arthritis (RA) patients taking methotrexate (MTX).
    Dorazco-Barragan, G
    Ramos-Remus, C
    Acevez-Avila, FJ
    Alcaraz-Lopez, F
    Fuentez-Ramirez, F
    Michael-Diaz, J
    Torrez-Bugarin, O
    Ventura-Aguilar, A
    Guadalajara, GZ
    [J]. ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S127 - S127
  • [34] PREVENTION OF DEVELOPMENT OF RHEUMATOID ARTHRITIS (RA) IN PATIENTS WITH UNDIFFERENTIATED ARTHRITIS (UA) BY VERY EARLY THERAPEUTIC INTERVENTION OF METHOTREXATE (MTX)
    Kudo-Tanaka, E.
    Matsushita, M.
    Tsuji, S.
    Hirao, M.
    Tsuboi, H.
    Katada, Y.
    Sueishi, M.
    Suenaga, Y.
    Chiba, J.
    Tonai, T.
    Saisho, K.
    Ogata, A.
    Hashimoto, J.
    Ohshima, S.
    Saeki, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 244 - 244
  • [35] Extracellular Microenvironment in Methotrexate (MTX): Treated rheumatoid arthritis patients
    Butur, G.
    Ardeleanu, C.
    Predeteanu, D.
    Manda, G.
    Ursaciuc, C.
    Comanescu, M.
    [J]. VIRCHOWS ARCHIV, 2012, 461 : S126 - S126
  • [36] METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    SINNETT, MJ
    GROFF, GD
    RADDATZ, DA
    FRANCK, WA
    BERTINO, JS
    [J]. JOURNAL OF RHEUMATOLOGY, 1989, 16 (06) : 745 - 748
  • [37] Pharmacokinetics of Oral Methotrexate in Patients With Rheumatoid Arthritis
    Dalrymple, Judith M.
    Stamp, Lisa K.
    O'Donnell, John L.
    Chapman, Peter T.
    Zhang, Mei
    Barclay, Murray L.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3299 - 3308
  • [38] Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis
    Ranganathan, Prabha
    Culverhouse, Robert
    Marsh, Sharon
    Mody, Ami
    Scott-Horton, Tiffany J.
    Brasington, Richard
    Joseph, Amy
    Reddy, Virginia
    Eisen, Seth
    McLeod, Howard L.
    [J]. JOURNAL OF RHEUMATOLOGY, 2008, 35 (04) : 572 - 579
  • [39] TOXICITY OF METHOTREXATE (MTX) COMPARED TO AZATHIOPRINE (AZA) THERAPY IN RHEUMATOID-ARTHRITIS (RA)
    MCKENDRY, RJR
    [J]. CLINICAL AND INVESTIGATIVE MEDICINE, 1987, 10 (04): : B124 - B124
  • [40] THE EFFECT OF SUBCUTANEOUS (SC) METHOTREXATE (MTX) AND ADALIMUMAB (ADA) ON CYTOKINE PROFILE IN MTX-NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (RA)
    Avdeeva, A. S.
    Novikov, A. A.
    Aleksandrova, E. N.
    Karateev, D. E.
    Luchihina, E. L.
    Nasonov, E. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 215 - 216
12345